Literature DB >> 444281

Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administration.

S Fahn, R Comi, S R Snider, A L Prasad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 444281     DOI： 10.1016/0006-2952(79)90333-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferase.

Authors:  J Nuutila; S Kaakkola; P T Männistö
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 2.  The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors:  M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal:  Experientia       Date:  1984-11-15

3.  Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.

Authors:  A Fredriksson; T Archer
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.

Authors:  A Reches; D Jiang; S Fahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.